Cortes P, Dumler F, Venkatachalam K K, Goldman J, Sastry K S, Venkatachalam H, Bernstein J, Levin N W
Kidney Int. 1981 Oct;20(4):491-9. doi: 10.1038/ki.1981.166.
Incorporation in vivo of labeled orotate into RNA and total nucleotides was measured in isolated glomeruli and whole renal cortex. In 2-day diabetic animals, glomerular RNA was increased, and there was greater incorporation of orotate into total nucleotides and RNA as compared with controls. Insulin reversed the exaggerated incorporation at infusion rates that corrected hyperglucagonemia without reducing plasma glucose and with only minimal changes in insulin concentrations. The addition of glucagon to insulin infusions reproduced the increased incorporation observed in untreated diabetics. Similar changes occurred in renal cortex, where differences in orotate incorporation into nucleotide precursors seemed to be the main cause for alterations in RNA labeling. Isotope incorporation in glomeruli correlated positively with plasma glucagon, but not with insulin or glucose concentrations. Although in 7-month diabetic animals orotate incorporation into RNA was less than in controls, probably as a consequence of renal disease, 24-hour insulin infusion decreased it further. Our results confirm that in the diabetic kidney, abnormal uracil nucleotide metabolism and increased cellular content of RNA are demonstrable in glomeruli as in the renal cortex. These changes appear to be related directly to hyperglucagonemia.
在分离的肾小球和整个肾皮质中测量了体内标记乳清酸盐掺入RNA和总核苷酸的情况。在2天龄的糖尿病动物中,肾小球RNA增加,与对照组相比,乳清酸盐掺入总核苷酸和RNA的量更多。胰岛素以纠正高胰高血糖素血症而不降低血糖且胰岛素浓度仅有微小变化的输注速率逆转了这种过度掺入。在胰岛素输注中加入胰高血糖素重现了在未治疗的糖尿病动物中观察到的掺入增加。肾皮质也出现了类似变化,乳清酸盐掺入核苷酸前体的差异似乎是RNA标记改变的主要原因。肾小球中的同位素掺入与血浆胰高血糖素呈正相关,但与胰岛素或葡萄糖浓度无关。虽然在7月龄的糖尿病动物中,乳清酸盐掺入RNA的量比对照组少,这可能是肾脏疾病的结果,但24小时胰岛素输注使其进一步减少。我们的结果证实,在糖尿病肾脏中,肾小球和肾皮质一样,可证明存在异常的尿嘧啶核苷酸代谢和RNA细胞含量增加。这些变化似乎与高胰高血糖素血症直接相关。